Pages that link to "Q33808728"
Jump to navigation
Jump to search
The following pages link to Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells (Q33808728):
Displaying 50 items.
- Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence (Q24534959) (← links)
- CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia (Q24557545) (← links)
- Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges (Q24812967) (← links)
- Maraviroc: a review of its use in HIV infection and beyond (Q26778504) (← links)
- Chronic alcohol abuse and HIV disease progression: studies with the non-human primate model (Q26852432) (← links)
- A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo (Q27313759) (← links)
- Use of alternate coreceptors on primary cells by two HIV-1 isolates (Q28259404) (← links)
- Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies (Q29619015) (← links)
- Going wild: lessons from naturally occurring T-lymphotropic lentiviruses (Q31066870) (← links)
- Discrepant amplification results during the development of an assay leads to reclassification of two AIDS reagent repository HIV-2 isolates as HIV-1. (Q33567901) (← links)
- Contributions of Mamu-A*01 status and TRIM5 allele expression, but not CCL3L copy number variation, to the control of SIVmac251 replication in Indian-origin rhesus monkeys (Q33619206) (← links)
- The variable loop 3 in the envelope glycoprotein is critical for the atypical coreceptor usage of an HIV-1 strain (Q33711710) (← links)
- Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytes (Q33716586) (← links)
- Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif (Q33717525) (← links)
- Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques (Q33841288) (← links)
- Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. (Q34010373) (← links)
- Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity (Q34123595) (← links)
- Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge (Q34178259) (← links)
- Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages (Q34226885) (← links)
- Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. (Q34226966) (← links)
- Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques (Q34228494) (← links)
- Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs (Q34332369) (← links)
- Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. (Q34340428) (← links)
- The mucosal immune system: primary target for HIV infection and AIDS. (Q34430862) (← links)
- Ancestral and consensus envelope immunogens for HIV-1 subtype C. (Q34539222) (← links)
- Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele (Q34545588) (← links)
- Vaccination with live attenuated simian immunodeficiency virus causes dynamic changes in intestinal CD4+CCR5+ T cells (Q34573745) (← links)
- HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage (Q34611466) (← links)
- Non-human primate models for AIDS vaccine research (Q34715769) (← links)
- The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. (Q34781878) (← links)
- Nonpathogenic CCR2-tropic SIVrcm after serial passage and its effect on SIVmac infection of Indian rhesus macaques (Q34976172) (← links)
- Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells (Q34996958) (← links)
- Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memory (Q35141486) (← links)
- Recombination-Mediated Changes in Coreceptor Usage Confer an Augmented Pathogenic Phenotype in a Nonhuman Primate Model of HIV-1-Induced AIDS (Q35274968) (← links)
- Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts (Q35616028) (← links)
- Cloning and analysis of sooty mangabey alternative coreceptors that support simian immunodeficiency virus SIVsmm entry independently of CCR5. (Q35665825) (← links)
- In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors (Q35666480) (← links)
- Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates (Q35738681) (← links)
- In vitro characterization of primary SIVsmm isolates belonging to different lineages. In vitro growth on rhesus macaque cells is not predictive for in vivo replication in rhesus macaques (Q35919086) (← links)
- Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates (Q35928777) (← links)
- Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins (Q35933555) (← links)
- Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection. (Q36371505) (← links)
- Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue (Q36399466) (← links)
- Antigenic conservation and immunogenicity of the HIV coreceptor binding site (Q36403587) (← links)
- GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine (Q36407775) (← links)
- Early Control of Highly Pathogenic Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimeric Virus Infections in Rhesus Monkeys Usually Results in Long-Lasting Asymptomatic Clinical Outcomes (Q36473475) (← links)
- Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge (Q36538907) (← links)
- A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus (Q36755525) (← links)
- Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249. (Q36802500) (← links)
- Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection (Q37009569) (← links)